MktsMarkets

Aktis Oncology, Inc.
NASDAQ: AKTSKey statistics
AKTS News
Stories mentioning AKTS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q1 '25Mar 31 |
|---|---|---|
| Income Statement | ||
| Revenue | 3,227 | 1,447 |
| Cost of Goods Sold | ||
| Gross Profit | ||
| Operating Expenses | ||
| Research & Development | 20,036 | 15,863 |
| Sales General & Admin | ||
| Total Operating Expenses | 25,933 | 19,590 |
| Operating Income (Loss) | (22,706) | (18,143) |
| Interest Income | 4,384 | 3,171 |
| Interest Expense | ||
| Other Expense | (3.00) | (13.00) |
| Pretax Income | ||
| Tax Provision | ||
| Net Income (Loss) | (18,325) | (14,985) |
| Earnings Per Share (Basic) | (0.38) | (18.60) |
| Earnings Per Share (Diluted) | (0.38) | (18.60) |
| Weighted Average Shares Outstanding (Basic) | 48,630 | 806.00 |
| Weighted Average Shares Outstanding (Diluted) | 48,630 | 806.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AKTS
Aktis Oncology, Inc. (NASDAQ: AKTS) is a stock listed on the Nasdaq Stock Market under the ticker symbol AKTS. It last traded at $16.31 (Nov 17, 2026, 4:00 PM ET), up 0.9% on the day. That gives Aktis Oncology a market capitalisation of $907.2M.
Over the past 52 weeks AKTS has traded between $13.96 and $34.19.
Revenue for the quarter ended Mar 31, 2026 was $3.2M; a net loss of $18.3M. Revenue was up 123% from $1.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $3.2M | -$18.3M | -567.9% |
| Mar 31, 2025 | $1.4M | -$15.0M | -1035.6% |
From Aktis Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…